Circa Group AS

Circa Group AS Financial Leverage

Delisted

The Financial Leverage (Equity Multiplier) of Circa Group AS (CIRCA.OL) as of Oct 23, 2026 is 1.23. In the previous year, Financial Leverage (Equity Multiplier) was 1.20 — a change of 2.85% (higher).

Financial Leverage

1.23

YoY

2.85%

Last updated:

Financial Leverage (Equity Multiplier) of Circa Group AS is 2023 1.23 . Financial Leverage (Equity Multiplier) of Circa Group AS was 2022 1.20 . It decreases by 2.85% higher compared to the previous year.

The Circa Group AS Financial Leverage history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Financial Leverage
Date
Financial Leverage
Jan 1, 2020
-18.68 EUR
Jan 1, 2021
1.13 EUR
Jan 1, 2022
1.20 EUR
Jan 1, 2023
1.23 EUR
The Circa Group AS Financial Leverage history
YEARFinancial LeverageYoY
1.23+2.85%
1.20+5.55%
1.13-106.06%
-18.68—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Circa Group AS Stock analysis

What does Circa Group AS do? Circa Group AS produces biochemicals through its proprietary Furacell process, converting biomass into advanced bio-based chemicals. The company's product portfolio includes Cyrene, a bio-solvent derived from Levoglucosenone (LGO), which serves as a greener alternative to traditional toxic solvents in paints, coatings, battery, and textile applications. The company develops flavorings, biopolymers, and bio-solvents under development, with Cyrene being a key product for industrial processes requiring safer solvents. Subsidiaries such as Circa Sustainable Chemicals Pty Ltd, Circa Sustainable Chemicals SAS, Circa Sustainable Chemicals BV, and Circa Group Pty. Ltd. support the company's global operations. Circa Group AS sells its biochemical products primarily to industries requiring sustainable chemical solutions, including paint and coating manufacturers, battery producers, and textile companies. The company's focus on eco-friendly solvents like Cyrene targets markets seeking safer alternatives to conventional toxic solvents. By leveraging its Furacell process, Circa Group AS differentiates its offerings as advanced bio-based chemicals with improved environmental and performance profiles. The company's revenue streams are derived from the sale of its biochemical products, particularly Cyrene and other bio-solvents, to industrial clients across multiple sectors. Its subsidiaries facilitate regional market access and operational efficiency, supporting the commercialization of its proprietary technology. As a biotechnology firm, Circa Group AS monetizes its proprietary Furacell process by converting biomass into high-demand sustainable chemicals. Circa Group AS is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Circa Group AS stock

Financial Leverage (Equity Multiplier) of Circa Group AS is 1.23 in 2023.

Financial Leverage (Equity Multiplier) of Circa Group AS changed from 1.20 to 1.23, representing a 2.85% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Financial Leverage (Equity Multiplier) Circa Group AS since 2006 – with annual values, charts, and detailed analysis.

Financial leverage, also known as the equity multiplier, measures total assets relative to equity. Higher leverage amplifies both returns and risks.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Financial Leverage (Equity Multiplier)'s Circa Group AS with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Leverage — Circa Group AS

Debt-to-EquityNet Debt / EBITDAInterest CoverageCurrent RatioQuick RatioCash RatioDebt / AssetsFinancial LeverageEquity RatioLT Debt/EquityNet Debt/EquityDebt/EBITDADSCRFinancial Debt RatioOCF/DebtFCF/DebtNet Debt/FCFDebt/Market Cap

All Key Metrics — Circa Group AS